Policy / Regulatory

NMPA Reports Record 61 Innovative Medical Device Approvals in 2023

CompanyDeals

Novartis to Acquire MorphoSys for €2.7 Billion in Strategic Oncology Expansion

CompanyDeals

Bayer Partners with TetraScience to Enhance Data Management in Product Development

CompanyDeals

Zhejiang Anglikang Enters R&D Cooperation Agreement with Affinity Biopharmaceutical

CompanyDeals

Novo Holdings to Acquire Catalent for $16.5 Billion in Strategic Move to Enhance Biopharmaceutical Capacity

CompanyDrug

MSD’s Keytruda Secures 13th Indication Approval in China for Biliary Carcinoma Treatment

CompanyMedical Device

Peijia Medical’s Taurus Atlas Pro Balloon Dilation Catheter Approved by NMPA for Pulmonary Valve Procedures

Company

MicroPort CRM Receives NMPA Approval for Next-Generation MRI-Safe Implantable Cardiac Pacing System

CompanyDeals

Jiangsu Wuzhong Pharmaceutical Partners with SPH KDL Health to Boost Aesthetics Product AestheFill

CompanyDrug

Konruns Pharmaceutical Commences Phase III Clinical Trial for KC1036 in Esophageal Cancer

CompanyDeals

Luye Pharma Grants Myung In Pharm Rights to Rivastigmine Patch for Alzheimer’s Treatment in South Korea

CompanyDeals

Abbisko Therapeutics Secures $70 Million Upfront Payment in Licensing Deal with Merck KGaA